Programmable polymeric drugs
US12098161B2 · kind B2 · utility
0Cited by
83References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2022 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Mar 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G79/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I): or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, L, L1, L2, L3, M and n are as defined herein. Methods associated with preparation and use of such compounds is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.